• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atypical pemphigus developed in a patient with urothelial carcinoma treated with nivolumab.

作者信息

Ito Michiko, Hoashi Toshihiko, Endo Yuki, Kimura Go, Kondo Yukihiro, Ishii Norito, Hashimoto Takashi, Funasaka Yoko, Saeki Hidehisa

机构信息

Department of Dermatology, Nippon Medical School, Tokyo, Japan.

Department of Urology, Nippon Medical School, Tokyo, Japan.

出版信息

J Dermatol. 2019 Mar;46(3):e90-e92. doi: 10.1111/1346-8138.14601. Epub 2018 Aug 31.

DOI:10.1111/1346-8138.14601
PMID:30168864
Abstract
摘要

相似文献

1
Atypical pemphigus developed in a patient with urothelial carcinoma treated with nivolumab.一名接受纳武单抗治疗的尿路上皮癌患者发生了非典型天疱疮。
J Dermatol. 2019 Mar;46(3):e90-e92. doi: 10.1111/1346-8138.14601. Epub 2018 Aug 31.
2
Nivolumab-induced lichen planus pemphigoides.纳武单抗诱发的类天疱疮样扁平苔藓。
Cutis. 2019 Apr;103(4):224-226.
3
Eruptive porokeratosis under nivolumab adjuvant treatment for melanoma.
Int J Dermatol. 2019 Jul;58(7):e138-e140. doi: 10.1111/ijd.14415. Epub 2019 Feb 27.
4
[Use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the upper urinary tract].[化疗和放疗在上尿路尿路上皮癌治疗中的应用]
Cancer Radiother. 2015 Apr;19(2):120-6. doi: 10.1016/j.canrad.2014.11.012. Epub 2015 Mar 11.
5
Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma.肌层浸润性膀胱癌和上尿路尿路上皮癌的辅助治疗
Urol Clin North Am. 2018 May;45(2):257-266. doi: 10.1016/j.ucl.2017.12.010. Epub 2018 Feb 21.
6
New onset of psoriasis during nivolumab treatment for lung cancer.在使用纳武单抗治疗肺癌期间新发银屑病。
J Dermatol. 2018 Mar;45(3):e55-e56. doi: 10.1111/1346-8138.14167. Epub 2017 Dec 4.
7
Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab.一名接受纳武单抗治疗的宫颈鳞状细胞癌患者出现自发消退的爆发性角化棘皮瘤。
J Dermatol. 2019 May;46(5):e177-e178. doi: 10.1111/1346-8138.14684. Epub 2018 Oct 24.
8
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.利妥昔单抗治疗纳武单抗诱导的大疱性类天疱疮。
JAMA Dermatol. 2017 Jun 1;153(6):603-605. doi: 10.1001/jamadermatol.2017.0091.
9
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.欧洲泌尿外科学会上尿路上皮细胞癌指南：2015 年更新版。
Eur Urol. 2015 Nov;68(5):868-79. doi: 10.1016/j.eururo.2015.06.044. Epub 2015 Jul 16.
10
Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma.在一名黑色素瘤患者接受纳武单抗治疗期间，无晕良性黑素细胞痣中免疫反应的诱导。
JAMA Dermatol. 2017 Aug 1;153(8):832-834. doi: 10.1001/jamadermatol.2017.0615.

引用本文的文献

1
[Drug-related exanthema under immunotherapy and targeted oncological therapy].[免疫疗法和靶向肿瘤治疗下的药物相关皮疹]
Dermatologie (Heidelb). 2024 Jun;75(6):440-450. doi: 10.1007/s00105-024-05350-7. Epub 2024 May 21.
2
HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.HLA遗传作为检查点抑制剂相关自身免疫性不良事件评估中的一个潜在参数。
Front Med (Lausanne). 2024 Jan 8;10:1288844. doi: 10.3389/fmed.2023.1288844. eCollection 2023.
3
Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review.
寻常型天疱疮作为免疫相关不良反应在接受伊匹单抗联合纳武利尤单抗治疗复发性转移性食管鳞状细胞癌中的表现：一例病例报告并文献复习。
Front Immunol. 2023 Sep 11;14:1259071. doi: 10.3389/fimmu.2023.1259071. eCollection 2023.
4
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.接受免疫治疗的癌症患者中的自身免疫性大疱性皮肤病：文献综述及意大利多中心经验
Front Med (Lausanne). 2023 Jul 20;10:1208418. doi: 10.3389/fmed.2023.1208418. eCollection 2023.
5
A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy.与抗癌治疗相关的大疱性皮肤不良事件综述
Biomedicines. 2023 Jan 24;11(2):323. doi: 10.3390/biomedicines11020323.
6
The multifactorial complexities of autoimmune development in Pemphigus vulgaris: Critical evaluation of the role of environmental and lifestyle "exposome" factors.寻常型天疱疮自身免疫发病的多因素复杂性：环境和生活方式“暴露组”因素作用的批判性评估。
Front Immunol. 2023 Jan 10;13:1058759. doi: 10.3389/fimmu.2022.1058759. eCollection 2022.
7
Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma.病例报告：接受西米普利单抗治疗的多灶性局部晚期皮肤鳞状细胞癌患者并发自身免疫性寻常型天疱疮
Front Oncol. 2021 Aug 23;11:691980. doi: 10.3389/fonc.2021.691980. eCollection 2021.
8
Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma.帕博利珠单抗治疗尿路上皮癌患者时出现的副肿瘤性天疱疮。
JAAD Case Rep. 2021 Feb 23;10:82-84. doi: 10.1016/j.jdcr.2021.02.012. eCollection 2021 Apr.
9
Recurrence of Pemphigus Vulgaris Under Nivolumab Therapy.寻常型天疱疮在纳武单抗治疗下的复发
Front Med (Lausanne). 2019 Nov 12;6:262. doi: 10.3389/fmed.2019.00262. eCollection 2019.
10
Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.抗程序性死亡-1派姆单抗治疗并发化脓性汗腺炎的皮肤鳞状细胞癌引发的副肿瘤性天疱疮
Front Med (Lausanne). 2019 Nov 5;6:249. doi: 10.3389/fmed.2019.00249. eCollection 2019.